The FDA received an application for Nubeqa as a potential treatment option with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer.

The FDA announced that it has accepted the supplemental sNDA for roflumilast foam 0.3% in those with scalp and body psoriasis over 12.

Hundreds of foods are recalled by the FDA every year. Food recalls could fall into different categories, depending on how ...

Announces completion of enrollment in its oral allergen challenge study for the development of its late-stage pipeline program, Anaphylm™ ...

Bristol Myers Squibb stock jumped after the pharma company won approval for its new schizophrenia drug late Thursday. “This ...

The Bristol Myers Squibb medicine is said relieve symptoms without causing some of the harsh side effects of drugs already in use. Meanwhile, thousands of patients allege in a lawsuit that drugs used ...

The U.S. Food & Drug Administration has accepted Aptar Pharma's N-Sorb nitrosamine mitigation solution into its Emerging ...

The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and ...

The gene therapy comes seven years after another research group at the university helped come up with the first FDA approved gene therapy for an inherited disease.

A popular podcast mentioned it earlier this year, sources say, but the FDA suggests users should be aware of unlisted ingredients.

The U.S. Food and Drug Administration (FDA) on Thursday approved Cobenfy (xanomeline and trospium chloride), developed by ...

(Alliance News) - PureTech Health PLC on Friday said KarXT has received US Food & Drug Administration approval for treating schizophrenia.